{"id":"https://openalex.org/W2049304391","doi":"https://doi.org/10.1086/522557","title":"Optimizing Treatment Outcomes in HIV-Infected Patients with Substance Abuse Issues","display_name":"Optimizing Treatment Outcomes in HIV-Infected Patients with Substance Abuse Issues","alternate_titles":[],"publication_year":2007,"publication_date":"2007-12-15","ids":{"openalex":"https://openalex.org/W2049304391","doi":"https://doi.org/10.1086/522557","mag":"2049304391","pmid":"https://pubmed.ncbi.nlm.nih.gov/18190306"},"language":"en","primary_location":{"id":"doi:10.1086/522557","doi":"https://doi.org/10.1086/522557","is_oa":false,"landing_page_url":"https://doi.org/10.1086/522557","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2049304391"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5021858666","display_name":"David D. Celentano","orcid":"https://orcid.org/0000-0002-6061-8799","observed_orcids":["https://orcid.org/0000-0002-6061-8799"]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"David D. Celentano","raw_affiliation_strings":["Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. dcelenta@jhsph.edu","Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland 21205, USA. dcelenta@jhsph.edu","institution_ids":["https://openalex.org/I145311948"]},{"raw_affiliation_string":"Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, and Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5010137365","display_name":"Greg M. Lucas","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I145311948","display_name":"Johns Hopkins University","ror":"https://ror.org/00za53h95","country_code":"US","type":"education","lineage":["https://openalex.org/I145311948"]},{"id":"https://openalex.org/I2799853436","display_name":"Johns Hopkins Medicine","ror":"https://ror.org/037zgn354","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799853436"]}],"countries":["US"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Greg Lucas","raw_affiliation_strings":["Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Infectious Diseases, Department of Medicine, Johns Hopkins School of Medicine, Baltimore, Maryland","institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5021858666"],"corresponding_institution_ids":["https://openalex.org/I145311948","https://openalex.org/I2799853436"],"apc_list":{"value":4763,"currency":"USD","value_usd":4763},"apc_paid":null,"fwci":1.4826,"has_fulltext":true,"cited_by_count":37,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.80486984,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":87,"max":98},"biblio":{"volume":"45","issue":"Supplement_4","first_page":"S318","last_page":"S323"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.698199987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.698199987411499,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11860","display_name":"HIV, Drug Use, Sexual Risk","score":0.1485999971628189,"subfield":{"id":"https://openalex.org/subfields/2713","display_name":"Epidemiology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.06469999998807907,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/hiv-infection","display_name":"HIV infection","score":0.9869999885559082},{"id":"https://openalex.org/keywords/substance-abuse","display_name":"substance abuse","score":0.9760000109672546},{"id":"https://openalex.org/keywords/drug-abuse","display_name":"drug abuse","score":0.7480000257492065},{"id":"https://openalex.org/keywords/opioid-use","display_name":"opioid use","score":0.5709999799728394},{"id":"https://openalex.org/keywords/highly-active-antiretroviral-therapy","display_name":"highly active antiretroviral therapy","score":0.9169999957084656},{"id":"https://openalex.org/keywords/treatment-adherence","display_name":"medication adherence","score":0.7979999780654907},{"id":"https://openalex.org/keywords/virological-outcomes","display_name":"virological outcomes","score":0.8080000281333923},{"id":"https://openalex.org/keywords/hiv-disease-progression","display_name":"HIV disease progression","score":0.7850000262260437}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9000909924507141},{"id":"https://openalex.org/C40010229","wikidata":"https://www.wikidata.org/wiki/Q3184856","display_name":"Substance abuse","level":2,"score":0.6947762966156006},{"id":"https://openalex.org/C2780035454","wikidata":"https://www.wikidata.org/wiki/Q8386","display_name":"Drug","level":2,"score":0.5582787990570068},{"id":"https://openalex.org/C27415008","wikidata":"https://www.wikidata.org/wiki/Q7256382","display_name":"Psychological intervention","level":2,"score":0.520865261554718},{"id":"https://openalex.org/C203014093","wikidata":"https://www.wikidata.org/wiki/Q101929","display_name":"Immunology","level":1,"score":0.46295151114463806},{"id":"https://openalex.org/C3013748606","wikidata":"https://www.wikidata.org/wiki/Q15787","display_name":"Human immunodeficiency virus (HIV)","level":2,"score":0.44485798478126526},{"id":"https://openalex.org/C535046627","wikidata":"https://www.wikidata.org/wiki/Q30612","display_name":"Clinical trial","level":2,"score":0.4280601441860199},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.3373109698295593},{"id":"https://openalex.org/C177713679","wikidata":"https://www.wikidata.org/wiki/Q679690","display_name":"Intensive care medicine","level":1,"score":0.3233721852302551},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3107887804508209}],"mesh":[{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006297","descriptor_name":"Health Services Accessibility","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010349","descriptor_name":"Patient Compliance","qualifier_ui":"Q000706","qualifier_name":"statistics & numerical data","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000401","qualifier_name":"mortality","is_major_topic":false},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000150","qualifier_name":"complications","is_major_topic":true},{"descriptor_ui":"D019966","descriptor_name":"Substance-Related Disorders","qualifier_ui":"Q000628","qualifier_name":"therapy","is_major_topic":false},{"descriptor_ui":"D023241","descriptor_name":"Antiretroviral Therapy, Highly Active","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D044966","descriptor_name":"Anti-Retroviral Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1086/522557","doi":"https://doi.org/10.1086/522557","is_oa":false,"landing_page_url":"https://doi.org/10.1086/522557","pdf_url":null,"source":{"id":"https://openalex.org/S72350973","display_name":"Clinical Infectious Diseases","issn_l":"1058-4838","issn":["1058-4838","1537-6591"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical Infectious Diseases","raw_type":"journal-article"},{"id":"pmid:18190306","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18190306","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Clinical infectious diseases : an official publication of the Infectious Diseases Society of America","raw_type":"Journal Article"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.1030.1356","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.1030.1356","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://cid.oxfordjournals.org/content/45/Supplement_4/S318.full.pdf","raw_type":"text"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":1.0}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320306342","display_name":"amfAR, The Foundation for AIDS Research","ror":"https://ror.org/02jesmk44"},{"id":"https://openalex.org/F4320307765","display_name":"Pfizer","ror":"https://ror.org/01xdqrp08"},{"id":"https://openalex.org/F4320307773","display_name":"GlaxoSmithKline","ror":"https://ror.org/01xsqw823"},{"id":"https://openalex.org/F4320308573","display_name":"Gilead Sciences","ror":"https://ror.org/056546b03"},{"id":"https://openalex.org/F4320332162","display_name":"Centers for Disease Control and Prevention","ror":"https://ror.org/042twtr12"},{"id":"https://openalex.org/F4320337355","display_name":"National Institute of Allergy and Infectious Diseases","ror":"https://ror.org/043z4tv69"}],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":39,"referenced_works":["https://openalex.org/W136034343","https://openalex.org/W1965192252","https://openalex.org/W1978673441","https://openalex.org/W1983537547","https://openalex.org/W1983596776","https://openalex.org/W1984949141","https://openalex.org/W1985877825","https://openalex.org/W1991197870","https://openalex.org/W1992620115","https://openalex.org/W1998281290","https://openalex.org/W2002479512","https://openalex.org/W2004996866","https://openalex.org/W2015127450","https://openalex.org/W2021546924","https://openalex.org/W2025835345","https://openalex.org/W2027919092","https://openalex.org/W2049436005","https://openalex.org/W2052940672","https://openalex.org/W2056599181","https://openalex.org/W2074151508","https://openalex.org/W2080407003","https://openalex.org/W2087919519","https://openalex.org/W2099574296","https://openalex.org/W2101881212","https://openalex.org/W2124701531","https://openalex.org/W2124769253","https://openalex.org/W2125891519","https://openalex.org/W2126608268","https://openalex.org/W2140150768","https://openalex.org/W2141870513","https://openalex.org/W2147656658","https://openalex.org/W2149789275","https://openalex.org/W2155825681","https://openalex.org/W2156330207","https://openalex.org/W2156820347","https://openalex.org/W2168779717","https://openalex.org/W2173615181","https://openalex.org/W2321988502","https://openalex.org/W4254292642"],"related_works":["https://openalex.org/W2069814052","https://openalex.org/W1990535097","https://openalex.org/W2181978915","https://openalex.org/W1646250315","https://openalex.org/W84457523","https://openalex.org/W1990101902","https://openalex.org/W1999480157","https://openalex.org/W2055135903","https://openalex.org/W2080407003"],"abstract_inverted_index":{"Drug":[0,84],"abuse":[1,63,85,134],"is":[2,68,86,94],"associated":[3,87],"with":[4,12,88,97],"poorer":[5,98],"virologic":[6,99,105],"and":[7,24,41,100,106,117,132,145],"clinical":[8,49,101,107],"outcomes":[9,147],"for":[10,136,150],"patients":[11],"human":[13],"immunodeficiency":[14],"virus":[15],"(HIV)":[16],"infection.":[17,152],"Limited":[18],"evidence,":[19],"primarily":[20],"from":[21],"in":[22],"vitro":[23],"animal":[25],"studies,":[26],"shows":[27],"that":[28,57,72],"some":[29],"abused":[30],"drugs":[31],"(e.g.,":[32],"opioids)":[33],"may":[34,73],"have":[35],"direct":[36],"effects":[37,50,108],"on":[38,64],"HIV":[39,65,151],"pathology":[40],"the":[42,48,58,104,127],"immune":[43],"response":[44],"to":[45,78,91,122,140,143],"infection,":[46],"but":[47],"are":[51,111],"not":[52],"known.":[53],"Clinical":[54],"data":[55],"indicate":[56],"primary":[59],"effect":[60],"of":[61,109,129,148],"drug":[62,115,138],"disease":[66],"progression":[67],"mediated":[69],"via":[70],"factors":[71],"limit":[74],"access":[75],"and/or":[76],"adherence":[77,90,142],"highly":[79],"active":[80],"antiretroviral":[81],"therapy":[82],"(HAART).":[83],"reduced":[89],"HAART,":[92],"which":[93],"strongly":[95],"correlated":[96],"outcomes.":[102],"However,":[103],"HAART":[110,144],"generally":[112],"equivalent":[113],"among":[114],"abusers":[116,119],"non-drug":[118],"who":[120],"adhere":[121],"therapy.":[123],"These":[124],"results":[125],"underscore":[126],"importance":[128],"integrating":[130],"medical":[131],"substance":[133],"interventions":[135],"HIV-positive":[137],"abusers,":[139],"improve":[141],"optimize":[146],"treatment":[149]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2049304391","counts_by_year":[{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":2},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":1},{"year":2016,"cited_by_count":6},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":3},{"year":2013,"cited_by_count":1},{"year":2012,"cited_by_count":2}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
